|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.MX |
First Approval Date18 Jun 2007 |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension
The main objective of this study is to determine the efficacy of early administration of Sanvar® in combination with endoscopic treatment for the control of acute variceal bleeding.
100 Clinical Results associated with Debiovision, Inc.
0 Patents (Medical) associated with Debiovision, Inc.
100 Deals associated with Debiovision, Inc.
100 Translational Medicine associated with Debiovision, Inc.